INTRODUCTION
Understanding the basis of individual variation is a central goal in genetics and epigenetics. The advent of global gene expression and chromatin-mapping technologies has greatly increased our understanding of gene regulatory mechanisms (Degner et al., 2012; Kasowski et al., 2013; McVicker et al., 2013; Vernot et al., 2012; Whitney et al., 2003) . However, prior methods often required tens of millions of cells. Investigators were forced to expand cells through artificial means, such as immortalization or extensive ex vivo expansion-manipulations that can significantly alter the regulatory landscape. Hence, prior studies have focused on the impact of inherited genetic variation on gene expression or chromatin states (Degner et al., 2012; Kasowski et al., 2013; McVicker et al., 2013; Vernot et al., 2012) , but the fidelity and variation of the human gene regulatory landscape in vivo are surprisingly not known.
Assay of Transposase Accessible Chromatin with sequencing (ATAC-seq) is a recently introduced and sensitive method to map open chromatin sites, predicted transcription factor finding, and nucleosome position from as few as 500 cells (Buenrostro et al., 2013; Lara-Astiaso et al., 2014; Lavin et al., 2014) , or even in single cells (Buenrostro et al., 2015; Cusanovich et al., 2015) . Such a comprehensive molecular portrait of predicted gene regulatory events affords a ''personal regulome''-a summary of gene regulatory events in a snapshot of time within a single individual. Although ATAC-seq provides a possible approach to investigate primary human cell types and minute clinical samples, the feasibility and accuracy of large-scale applications have not been demonstrated. Here, we generate and analyze 58 high-resolution personal regulomes of a single cell typehuman CD4+ T cells-that comprised over 1.7 billion measurements. We develop methods to integrate diverse sources of genomic and epigenomic information to address the regulatory variation as a function of individuality, time, and disease ( Figure 1A ).
RESULTS

Landscape and Variation of Personal Regulomes in CD4+ T Cells
We assessed the landscape and variation of chromatin accessibility in human CD4+ T cells in 33 samples provided by 12 healthy donors ( Figure 1A ). In this exploratory study, we wanted to document dominant sources of regulome variation readily evident from small numbers of healthy individuals; other well-selected and larger populations are likely to reveal many other potential contributions to regulome variation. Most donors gave at least two independent samples, days to months apart; one donor was sampled six times over 7 months (Table S1 ). From each standard 5-ml blood draw, we enriched at least 50,000 CD4+ T cells by negative selection without ex vivo expansion (avoiding potentially activating antibodies in positive selection) and performed ATAC-seq to map the location and accessibility of regulatory elements genome-wide (Supplemental Experimental Procedures). CD4+ T cells include multiple subsets (including naive, memory Th1, Th2, Th17, Treg, and Tfh cells); known frequency counts suggest that these major subsets would be sampled by our approach (Maecker et al., 2012) . Each library was sequenced to obtain, on average, more than 30 million paired-end reads. We used ZINBA (zero-inflated negative binomial algorithm) (Rashid et al., 2011) to identify focal peaks of chromatin accessibility that typify active regulatory elements, and sequence counts within accessibility peaks were subjected to quantile normalization to yield a quantitative portrait of active regulatory elements in each sample. Pearson correlation of replicates and irreproducibility discovery rate (IDR) analysis (Landt et al., 2012) indicate high quality of the data and excellent reproducibility between replicates (Figures S1A-S1D). Systematic comparison of published ATAC-seq peaks to histone modification and DNase I hypersensitivity sequencing (DHS-seq) confirmed that ATAC-seq highlights active enhancers and promoters (Figures S1E and S1F).
To identify individual variation in T-cell regulomes, we applied intrinsic analysis (Perou et al., 2000) , a method that highlighted elements that varied in accessibility across individuals but not between repeat samples from the same individual ( Figure 1B ). Noisy measurements that vary regardless of donor identity are filtered out by this approach. We also used permutation analysis as further protection against noisy data, using signals in observed, but not permuted, data to estimate false discovery rate (FDR) (Supplemental Experimental Procedures). The selected elements reveal complex but distinctive patterns of activity, so that replicate samples from the same donor at a same time were always clustered together in unsupervised hierarchical clustering (12 of 12 pairs). Correlation of the pattern of regulome activity with known subject variables revealed potential relationships with gender, self-reported ancestry, and other individual variation (p < 0.01, FDR < 0.05; Figures 1B and 1C) . As CD4+ cells comprise several subsets, the individual variation observed may reflect variations in cell subset composition in addition to gene-specific regulation. Comparison of chromatin accessibility data (by DNase I hypersensitivity) from purified T-cell subsets, including Th1, Th2, Th17, and Treg cells, suggests that some of the regulome variation may be correlated with cell subsets (Figure 1B, right) . CD4+ T cells from healthy donors exhibited 66,344 accessible sites in our survey, inferred to be active regulatory elements ( Figure 1C ). Approximately 92.8% of these sites showed invariant activity across individuals and time, indicating a high degree of fidelity in the regulatory landscape. Nearly 7.2% of accessible sites (4,769 elements) show significant variable activity (Z score > 1, FDR < 0.1, and fold change > 5). 24.7% of these elements varied in accessibility in the same individual over time and, hence, may reflect dynamic regulation of the immune system ( Figure 1C ). The remainder elements showed stable inter-individual differences, which can be associated with known variables with different degrees of confidence ( Figure 1D ). Notably, gender is the most informative variable, being strongly associated (p < 10 À10 ) with differential activity of several hundred elements. In all cases, self-reported gender was concordant with biological sex as determined by chromosome complement (discussed later). In contrast, potentially regulatory impact from ancestry was less significant in this cohort, and differential accessibility attributable to individual or dynamic differences is weakly but broadly associated with thousands of elements. Many elements currently assigned to the ''individual'' category are idiosyncratic in their differential activity; many are ''private'' variations that are observed reproducibly in one donor but not across multiple individuals in our survey. Notably, although some of the dynamic and individual variation correlated with Th1 versus Th2 signals, gender-the most significant variable-is not appreciably associated with known cell subsets ( Figure 1B ). The variable elements are enriched for distal regulatory elements and depleted for promoters, suggesting variation in long-range gene regulation ( Figures 1E and 1F ).
Gender-Specific Regulome in T Cells
Next, we focused on gender-specific variation in the T-cell regulome, because it emerged as the most significant attributable source of inter-individual variation and because well-studied mechanisms of dosage compensation provided a rich interpretative framework for understanding our data. In mammals, males have XY sex chromosomes, whereas females have XX. Dosage compensation occurs via random epigenetic silencing of one of the two female X chromosomes, termed X chromosome inactivation (XCI), which is heritable through somatic cell divisions over life (Flynn and Chang, 2014; Lee and Bartolomei, 2013) . XCI is controlled by several long noncoding RNAs (lncRNAs), including XIST, which is transcribed from and mediates the epigenetic silencing of the inactive X chromosome (Xi). Thus, the active X chromosome (Xa) and Xi harbor distinct chromatin modifications and gene expression patterns. A subset of X-linked genes escape from XCI in a tissue-specific fashion through poorly understood mechanisms, leading to differential X-linked expression in male versus female cells.
Among regulatory elements with significant differential activity between male and female cells, a majority (but not all) mapped to the sex chromosomes (Figures 2A and 2B ). As expected, only male samples showed signal for Y-chromosome-linked elements, and female samples showed increased activity of X-chromosome-linked elements. Gender-specific regulomes may arise from effect of sex-specific hormones, random X inactivation, X-linked escapee genes, or additional differences (Rubtsova et al., 2015) . Sex hormone changes may impact all chromosomes, whereas the XCI effects are linked to the X chromosome.
Comparative analysis of regulatory activity between males and females across autosomes (e.g., chromosome 1) revealed equivalent activity profiles at the chromosomal level, as evidenced by a slope of 1 in the two-dimensional plot ( Figure 2C ). In contrast, a comparison of males and females across the X chromosome readily revealed three types of elements: (1) elements that are dosage compensated and, therefore, have equivalent activity between males and females (slope = 1, gray dots in Figure 2D ); (2) active elements on the Xi and, therefore, are only active in female cells (slope = infinity; purple dots in Figure 2D ; e.g., XIST); and (3) elements that escape XCI and, therefore, show a 2-fold increase in activity in female over male cells (slope = 2; red, blue, and black dots in Figure 2D ).
We identified 43 elements associated with 17 coding genes (e.g., EIF1AX and KDM6A) and 3 noncoding genes known to escape XCI, as well as elements associated with 7 escapees predicted by others and 12 XCI escapees that, to our knowledge, have not been reported previously (Figures 2D and S2;  Table S2 ). We analyzed the ImmVar dataset, which measured genome-wide mRNA levels of CD4+ T cells from 163 healthy male and 244 female donors (Ye et al., 2014) . Gender-specific gene expression profiles validated 16 out of 17 known XCI genes and 6 of 7 novel XCI escapees predicted by ATAC-seq that had well-measured transcripts ( Figure S3A ). We note that escapee genes that were not validated tend to have lower ATAC-seq signals and mRNA expression compared to those that were validated ( Figure 6 ), which may be below the detection confidence of array technology.
Genes that escape XCI in females offered us an opportunity to compare the accuracy and statistical power of ATAC-seq data versus standard microarray data (Ye et al., 2014) (Figure 2E ). Such genes are anticipated to have a 2:1 dosage ratio in females versus males. Whereas ATAC-seq analysis accurately identified the 2-fold ratio in female versus males across a range of gene activity levels ( Figure 2D ), microarrays underestimated the difference ( Figure S4 ). Using the known XCI escapees that are detected by both ATAC-seq and RNA microarray analysis (p value < 10 À4 , Student's t test) as positive controls, we performed a power analysis to determine the number of samples required to have a 95% probability of detecting this true difference with a significance level <0.01. ATAC-seq requires only 11 samples of each gender, while mRNA microarray requires 81 samples of each gender to reach a power of 0.95 ( Figure 2E ), indicating that ATAC-seq is over seven times more sensitive than microarray. The ability of ATAC-seq to detect rare elements (e.g., Y-linked sequences in males) and accurately quantify one versus two copies of X-linked activity suggests that our methods are sensitive and precise and could achieve excellent statistical power with a small sample size. The comparison of gender-specific regulomes also yielded unexpected insights that are not possible from gene expression measurements. For example, we observed that accessible elements that escape XCI are more likely to be found at promoters and introns of known escapee genes but not at intergenic distal regions ( Figure 2F ). Moreover, our analysis revealed evidence of gender-specific regulatory landscapes of XCI escapees (Figure 2G) . XCI escape has traditionally been considered simply a failure of Xi silencing; hence, it was believed that the regulatory pattern on the Xa will simply be duplicated on the Xi for escapee genes. Indeed, the term ''XCI escape'' implies this preconceived notion; however, there is no direct evidence to support or refute this model for XCI escape. We identified Xi-specific regulatory elements on XCI escapees, which have signal only in female, but not male, cells ( Figure 2D , purple dots). For instance, FIRRE is a recently described X-linked lncRNA that escapes XCI and is involved in chromosome topological organization (Hacisuleyman et al., 2014; Yang et al., 2015) . RNA in situ hybridization documented two equivalent RNA foci in female cells and one focus in male cells (Hacisuleyman et al., 2014) . FIRRE contains a series of putative intronic enhancers embedded throughout its locus, as documented by the enhancer-associated modification histone H3 lysine 27 acetylation (H3K27ac) in a survey of mixedsex cells . Intriguingly, our data suggest that two FIRRE enhancers in intron 2 are active in male cells, whereas over a dozen enhancers in introns 2-12 are active only in female cells ( Figure 2G ). This regulatory divergence implies gender-specific regulation, allele-specific regulation of FIRRE on Xa versus Xi, or combinations of both strategies.
Extending the concept of allelic regulatory divergence, the selection pressure for dosage compensation is thought to be the maintenance of the expression level of homologous gene pairs on the X and Y chromosomes (Bellott et al., 2014) . Analysis of the regulatory landscape of XY homolog pairs shows that all 15 pairs examined showed divergence on par with, or exceeding that of, FIRRE alleles, indicating that the regulatory inputs into the sex-linked gene homologs are distinctive as a rule ( Figures  S5A-S5C ). These results highlight the value of examining dosage compensation from the perspective of the personal regulome.
Gender-Specific Regulome of Autosomes Reveal Propensity for Autoimmunity
The dramatic chromatin accessibility differences between the genders on sex chromosomes prompted us to examine the scope of gender-specific differences on autosomes. Genderspecific regulomes for T cells have special relevance to human disease because of the strong epidemiological evidence indicating an association between female sex and autoimmunity (reviewed by Rubtsova et al., 2015) . Four out of five patients with any type of autoimmune disease are female; for some common diseases, such as systemic lupus erythematosus, the preponderance of females to males is nine to one. It has been long postulated that epigenetic or regulatory differences between male and female immune cells may underlie autoimmune susceptibility (Rubtsova et al., 2015) , but gender-specific differences are incompletely understood.
We sought to identify gender-specific differences in gene regulatory networks from ATAC-seq data (Figure 3) . DNA transposition occurs preferentially at nucleosome-free regions adjacent to transcription factor (TF) binding sites, but the TF binding sites themselves are protected from transposition. Hence, the pattern of ATAC-seq reads can directly reveal the binding profiles of hundreds of TFs whose cognate motifs are known at once (Buenrostro et al., 2013) . One caveat of this approach is that TF family members that bind similar motifs cannot be distinguished. To this end, for each ATAC-seq profile, we identified enriched TF motifs and factor footprints associated with ATACseq peaks to generate a matrix of predicted TF-to-gene relationships (Sherwood et al., 2014) ; the inferred regulation is weighted by the distance of the element to the transcription start site of each gene (Figures S5D and S5E ; Supplemental Experimental Procedures). The end result is a set of active TF regulators and their cognate sites on each gene for each individual. We then compared male versus female samples for differences in this predicted regulatory matrix (Figures 3A-3D ; Figure S6F ).
At the level of target genes, we found several hundred genes that show significant differences in their predicted regulatory network in male versus female T cells (Z score R 2; Figure 3B ; Table S3 ). The scale of variance-defined here as the pattern of regulation in one gender that differs from the regulatory pattern of the other gender (1 À the square of Pearson correlation of male versus female)-ranges from 0.13 to 0.61 for the top 100 genes; hence, such gender-specific variation is likely more modulatory than deterministic. Ranking autosomal genes by gender-specific regulatory variance revealed that the top divergent genes include many genes with well-known and important function in immune function or development, including FGL2, GZMK, IFNG, CRTAM, CARD16, FYN, IL2 , and IL6 ( Figure 3B ). Indeed, significant gender-specific differences in T-cell production of IFN-gamma and interleukin-2 (IL-2) have been documented in healthy children (Wiegering et al., 2009 ), validating our unbiased approach. IFN-gamma is also known to be affected by sex hormones (Rubtsova et al., 2015) . In addition, direct molecular counting via Nanostring nCounter analysis of GZMK, IL2, IL6, and NLRP2 transcripts indicates significant genderdivergent responses to T-cell activation ( Figure S3B ), which also supports our discovery (Ye et al., 2014) . In summary, among the top 500 predicted gender-specific genes, the mRNA levels of 30 were measured using Nanostring, of which 20 showed significant differential expression between males versus females (p < 0.05, Student's t test).
FGL2 stands out because it is the number one gene in the entire genome for gender-specific variance in chromatin accessibility and because the variance is nearly twice that of the next most variable gene ( Figure 3C ). FGL2 shows greater promoter ATAC-seq signal in male than in female T cells, and analysis of specific TF signals revealed that interferon-regulatory factor (IRF) family members and NHLH1 TFs are bound in male, but not female, T cells ( Figure 3C ). Notably, FGL2 encodes a fibrinogen-like protein secreted by regulatory T cells and other cells that has immunosuppressive activity (Marsden et al., 2003) . Mouse knockout showed that Fgl2 is required for Treg function and prevention of spontaneous autoimmunity (Shalev et al., 2008) . Similarly, CRTAM encodes a T-cell adhesion molecule that has been recently recognized to critically control the differentiation of CD4+ cells into inflammatory Th17 cells (Cortez et al., 2014) . Thus, gender-specific regulation of FGL2 and CRTAM (which, to our knowledge, has not been reported) may contribute, in part, to gender-linked differences for autoimmune disease.
Extending this concept to the top 1,000 differentially regulated genes, we note that these genes are significantly enriched for biological functions in defense response, response to virus, immune complex, and inflammatory disease (p < 10 À6 for each, FDR < 0.05, hypergeometric test; Figure 3F ). The regulatory elements of many well-expressed genes, such as housekeeping genes, are surveyed in these experiments but did not show gender-specific differences. Thus, gender-specific regulation in T cells is focused on genes with coherent biological function that impact immune function and autoimmunity.
To understand the mechanisms of gender-specific regulome divergence, we examined TF regulators that may exhibit gender-specific activity. In contrast to the $1,000 target genes, we observed just a handful of TFs with gender-associated divergence ( Figure 3D ; Table S3 ). Among the most divergent is ESR2 (encoding estrogen receptor beta); its differential can be understood based on the female hormone estrogen and serve as a positive control. The top divergent regulator maps to the cognate motif of ZBTB3, a little studied factor. ZBTB3 is poorly expressed in CD4+ cells; hence, this motif may be recognized by another zinc-finger family protein. Two notable gender-divergent regulators are IRF family members, encoding well-studied TFs activated by interferon signaling and other signals in innate and adaptive immunity responses that can cooperate or compete with other TFs to exert regulatory effects (Ikushima et al., 2013) . Thus, a large number of genes were differently regulated, but the differential regulation was associated with a small number of TF motifs that repeatedly showed differential activity across many genes. This result suggests that a small number of regulators may impact a large number of target genes to yield the observed male-female divergence in the regulome.
The IFNG locus emerged as a prime example of intersection of predicted regulatory divergence of both regulators and target genes ( Figures 3B and 3E) . IFNG is the third most divergent gene in our analysis. IFNG encodes interferon gamma and is a key regulator of immune response and Th1 cell differentiation. Multiple studies have documented gender-specific association of allelic variants at IFNG regulatory elements or IFNG protein levels with human disease. For example, IFNG variants are associated with multiple sclerosis (Kantarci et al., 2008) and asthma (Loisel et al., 2011) in males, but not females, but the mechanisms are not known. NeST (also known as IFNG-AS1 or TMEVPG1) is located proximal to IFNG and encodes an lncRNA that is required to program active chromatin state and promote expression of IFNG (Gomez et al., 2013) . NeST is convergently transcribed relative to IFNG, and a long isoform of NeST is transcribed through the IFNG promoter. NeST itself is induced by Th1 polarization , and murine NeST was first discovered as a genetic locus that controlled pathogen resistance and immune-mediated demyelinating disease (Bihl et al., 1999) .
We found that human IFNG and NeST show gender-specific regulation ( Figure 3E) . A cluster of elements nearest to 5 0 of IFNG is equally active in male versus female cells, but high-resolution analysis indicated that IRF family members occupied these sites more strongly in males, but NF-YA and CST6 did so in females. Males also have higher TF occupancy of NeST. These results suggest that positive regulatory loops comprising NeST, IRF, and IFNG may differ in a gender-specific fashion. Consistent with this idea, careful genetic analyses showed that NeST locus mutation has stronger pathogenic impact in male than in female mice (Bihl et al., 1999) . The fact that our unbiased approach, examining target genes and regulators, independently nominated IFNG highlights interferon signaling as a major gender-specific regulatory feature in T cells. Our results support the considerable epidemiologic and genetic evidence of IFNG involvement in gender variation of immune function and autoimmunity and enrich this evidence by nominating specific TFs and lncRNA as potential players in this mechanism.
T-Cell Chromatin Accessibility Variation Is Enriched at Sites of Causal Genetic Variants for Autoimmune Diseases
To understand how inherited DNA variation may underlie variations in personal regulomes, we intersected the set of variable regulatory elements with a previously curated set of SNPs, particularly SNPs linked to human diseases or variation in chromatin state or gene expression (Boyle et al., 2012; Farh et al., 2014) . Prior work indicated that most DNase I hypersensitive site quantitative trait loci (dsQTLs) with strong effect size acted in cis, meaning that they affected the chromatin feature where the SNP itself is located (Degner et al., 2012) . We identified the genotypes using sequencing information in ATAC-seq peaks and validated them by standard SNP genotyping of a subset of donors (Figures 4A and 4B; Figures S6A and S6B) . In addition, we imputed unmeasured SNPs by applying a standard imputation method IMPUTE2 (Howie et al., 2009 ), using haplotypes from the current version of 1000 Genomes as a reference. We found that 48% and 18% of the 4,769 variably active elements overlapped detected or imputed SNPs, respectively ( Figure 4C ). Thus, more than a third (36%) of regulome variation occurs in the absence of genetic variation in cis. Prior data further indicate that only a small minority (<1%) of SNPs can significantly explain variation in chromatin accessibility (Degner et al., 2012) . Additional contributions of personal regulome variation may include trans-acting genetic variants, environmental and epigenetic factors, and variations in cell subset composition.
We discovered that the intersection of personal regulome variation and genetic variation is highly relevant for human disease. We obtained SNP sets from the recently published set of causal autoimmune SNPs (Farh et al., 2014) ; genome-wide association studies (GWASs) and expression quantitative trait loci (eQTLs) SNPs from NCBI, HapMap, and dbSNP138; disease SNPs (of all organ systems) from RegulomeDB (Boyle et al., 2012) ; and de novo SNPs from donors (Supplemental Experimental Procedures). First, we asked whether ATAC-seq peaks of CD4+ T cells, representing active regulatory elements, are enriched in SNPs as a class compared to the remainder of the genome. Autoimmune casual SNPs are strongly enriched in CD4+ T-cell ATAC-seq peaks (p < 10 À15 , binomial test) ( Figure S6C ), consistent with the idea that causal genetic variants in autoimmune diseases impact immune cell enhancers (Farh et al., 2014) . Second, we tested whether ATAC-seq peaks that show inter-individual variation are enriched for disease or eQTL SNPs compared to invariant open chromatin sites in CD4+ T cells. We found that autoimmune causal SNPs were most significantly enriched in variable peaks compared to invariant open chromatin sites (Figure 4D) , including causal variants for type 1 diabetes, rheumatoid arthritis, lupus erythematosus, Crohn's disease, and vitiligo (Table S4) . As negative controls, generic SNP sets from GWASs of all diseases or eQTLs (which are not T cell specific) showed no significant enrichment. Collectively, these results illustrate the biological significance of the variable regulatory elements, and variability in chromatin accessibility across individuals emerges as a novel feature associated with locations of causal disease SNPs. Variable elements are, by definition, ''noisy'' and capable of being readily switched on or off-properties that may enable even a single-nucleotide mutation to change its activity (Farh et al., 2014) .
Regulome Dynamics in T-Cell Activation
Personal regulomes can also be interpreted with the help of in vitro experiments that create an interpretative framework. We measured changes in the chromatin accessibility caused by specific hypothesis-driven perturbations in vitro and examined whether any of the same changes occurred in patientderived samples in vivo. We illustrate this concept by assessing the regulome dynamics during T-cell activation. We isolated CD4+ cells from donor 1 and stimulated them with PMA and ionomycin; collected cells at 0, 1, 2, and 4 hr or 0 and 4 hr of unstimulated controls in duplicate; and performed ATAC-seq to map the regulatory elements genome-wide. We identified 1,513 regulatory elements that gained or lost accessibility upon T-cell activation from 1 to 4 hr ( Figure 5 ). 770 elements, mapping to 591 genes, gained accessibility (presumably induced), while 773 elements, mapping to 593 genes, lost accessibility (presumably repressed). By comparing genome-wide mRNA microarray data in normal human CD4+ T cells (Ye et al., 2014) , we found that, on average, genes that gained ATACseq signal showed significantly increased mRNA levels upon activation (p = 5 3 10 À16 ), and, conversely, genes that lost ATAC-seq signal also had decreased mRNA expression (p = 3 3 10
À4
; Figure 5A ). For gene loci that gain chromatin accessibility, 61 showed increased mRNA level by more than 2-fold in mRNA expression, while only one gene showed decreased mRNA level. Thus, chromatin accessibility and gene expression are highly concordant, as anticipated. This finding further validates the accuracy of ATAC-seq and our mapping of regulatory elements to genes. As expected, regulatory elements that gain accessibility during the T-cell activation show significant Gene Ontology enrichment in regulation of immune system processes, leukocyte activation, and immune response (p < 10
À10
; Figure 5b ). T-cell activation strongly activates a suite of genes, including IL-2, in part through the inducible TF NFAT (Northrop et al., 1994) . ATAC-seq data visualized enhancer activation at the IL2 locus and identified inducible TF footprints of NFAT that is validated by published NFAT ChIP-seq ( Figures 5C-5E ).
Next, we used the T-cell activation regulome to interpret personal regulome variation. We discovered that a set of regulatory elements exhibiting inter-individual variation strongly corresponded to elements that are coordinately deactivated with T-cell activation; this very same cluster is also associated with elevated Th2 gene signature ( Figure 5F , cluster ii). Thus, a previously unassigned set of personal regulome variation may be related to the state of T-cell activation in these donors. At a broader level, this new result illustrates the general concept that we can use ATAC-seq profiles from laboratory-based, welldefined perturbations or cell populations to interpret the complex regulome patterns observed in clinical samples across real populations. 
Regulome Variation in the Context of T-Cell Activation and Cancer
Finally, we explored the scope of regulome variation across individuals versus that with cell stimuli or a disease state. Although comparison of regulomes in disease versus health may be a powerful approach to understand disease mechanism, an underlying assumption in cross-sectional studies (i.e., comparing different individuals who are healthy versus sick at the same point in time) is that the disease-relevant variations significantly outnumber inter-individual variation-an assumption that needs to be tested. To this end, we compared ATAC-seq at four time points of human CD4+ T cells activated with ionomycin and phorbol ester (n = 10 samples), as well as leukemic CD4+ T cells isolated from patients in the leukemic phase of CD4+ cutaneous T-cell lymphoma (CTCL; n = 15 samples). We found that the regulome dynamics in cancer and T-cell activation are at least 10-to 100-fold greater than inter-individual variation (Figure 6 ). Notably, for the largest amplitude differences (>5-fold), the number of variable elements in these different states starts to converge, highlighting the importance of knowledge about inter-individual variation to interpret disease-associated data. T-cell activation may exhibit greater regulome variation in this analysis because the cell population is temporally synchronized with respect to stimulation, whereas the leukemia samples are not. These results demonstrate the feasibility of using these data as a foundational reference to which disease-associated regulomes can be compared. CTCL-specific regulome differences will be presented in detail elsewhere.
DISCUSSION
Here, we evaluate the feasibility of using a recently introduced and sensitive genomic technology, ATAC-seq, to visualize the personal regulome from a standard blood draw, the most common source of human samples for clinical diagnostics. This work expands the number of primary human cell samples studied via ATAC-seq by 20-fold, and we provide foundational data and methods to compare and visualize differences in personal regulome. We were able to enumerate the number, location, and potential sources of in vivo variation in chromatin accessibility on a genome-wide scale, providing several notable and unexpected findings. Our cohort was not designed to test many possible potential contributors of regulome variation, and lack of association here does not rule out their roles. Rather, these data serve as a starting point to understand potential sources of variation in chromatin accessibility in the population.
Our analyses suggest that sex is a major source of individual variation in the T-cell regulome. We demonstrated the capacity of ATAC-seq to detect even 2-fold differences in chromatin access, and many predicted regulome differences were validated by independent gene expression measurements. We identified X-linked chromatin accessibility sites that are more active in female versus male T cells, which nominated elements associated with escape from XCI in female cells. We further identified autosomal sites that have differential accessibility between sexes, which may relate to differences in sex hormones, indirect regulation from sex-chromosome dosage, or other sex-related associated differences (Rubtsova et al., 2015) . Variation between sexes has its root cause in genetics from the differential inheritance of sex chromosomes, which, in turn, leads to epigenetic differences in dosage compensation and organismal differences, such as different hormonal environments and life history events. These events are often linked to social or cultural roles that can also impact physiology. Our work adds to the increasing recognition of sexual dimorphism at the molecular level across many organs (Rinn et al., 2004) . Building on the large body of epidemiologic and clinical data for gender differences in immune function and autoimmunity, our results nominated specific genes, transcription factors, and predicted regulatory circuits as potential drivers of gender differences for future studies. Similarly, we found that the majority of the variations in the regulatory landscape may go beyond genetic variation; such regulatory variation may arise from epigenetic differences from life history or environmental factors, such as the microbiome that offers many opportunities for future investigations (Yurkovetskiy et al., 2013) . Regulome variation in CD4+ T cells derived from normal donors (green), during T-cell activation (blue), or in T-cell leukemia (red) are ranked and compared. There are 32, 517, and 1,800 regulatory elements in normal, T-cell leukemia, and T-cell activation, respectively, whose variance is greater than 2.
Finally, comparison of regulome variation in healthy donors versus those with disease documented the feasibility of using the personal regulome approach to investigate disease biomarkers and mechanisms. The added value of regulome analysis over mRNA biomarkers may arise from the fact that casual SNPs associated with human diseases predominantly impact distal enhancers (Farh et al., 2014) and, therefore, cannot be assessed by traditional mRNA measurements alone. Recent discovery of widespread allelic bias in enhancer-promoter interactions motivates the need for regulome analysis in addition to RNA measurements (Dixon et al., 2015) , as exemplified by our detection of the differential regulatory landscape of FIRRE in males versus females. Furthermore, regulome analysis may directly investigate chromatin or TF pathways that are direct drug targets. While useful, potential limitations of ATAC-seq for personal regulome prediction include Tn5 sequence bias, sensitivity as a function of sequencing depth, and cell-type heterogeneity. Integration of additional epigenomic measures, such as direct TF binding or enhancer RNA synthesis, may improve enhancer activity prediction (Dogan et al., 2015) . As more than 1 billion blood samples are obtained per year in the United States alone (Becich, 2000) , using ATAC-seq to monitor personal regulomes in health and disease offers many exciting possibilities.
EXPERIMENTAL PROCEDURES
Enrichment of CD4+ cells from peripheral blood, ATAC-seq, and primary data analysis were as described (Buenrostro et al., 2013) . Differential peaks were defined via intrinsic analysis, with a cutoff of Z score > 1, fold change > 5, and an FDR < 0.1. The variance of each peak was calculated using the ''var'' function in R. Gene ontology enrichment scores were obtained from GREAT. Statistical power analysis was performed using the ''pwr.t2n.test'' function in R. TF footprinting analysis was performed using PIQ v1.2 (Sherwood et al., 2014) , with input motifs set from JASPAR. Donor DNA was genotyped using Illumina HumanOmni2.5-8+ v1.1 DNA Analysis BeedChip Kits. De novo mutation calling was performed using VarScan v2.2.8, and unmeasured SNPs were imputed by IMPUTE2. Enrichments of SNP sets were estimated by binomial test in R.
Complete methods are available in the Supplemental Information. Computational script used are available in Data Analysis Codes (Data S1).
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